119 related articles for article (PubMed ID: 2897973)
1. Somatostatin-secreting islet cell tumor (somatostatinoma): suppression of growth hormone (GH) release induced by GH-releasing hormone.
Iguchi H; Kumagai S; Seo IH; Wakasugi H; Hara Y; Abe M
J Clin Endocrinol Metab; 1988 Jul; 67(1):206-10. PubMed ID: 2897973
[TBL] [Abstract][Full Text] [Related]
2. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors.
Mouhieddine OE; Levy L; Benlot C; Peillon F; Joubert D
J Clin Endocrinol Metab; 1995 May; 80(5):1691-5. PubMed ID: 7745020
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin injection increases growth hormone and somatostatin secretion in sheep.
Briard N; Guillaume V; Frachebois C; Rico-Gomez M; Sauze N; Oliver C; Dutour A
Endocrinology; 1998 Jun; 139(6):2662-9. PubMed ID: 9607770
[TBL] [Abstract][Full Text] [Related]
5. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep.
Magnan E; Cataldi M; Guillaume V; Mazzocchi L; Dutour A; Razafindraibe H; Sauze N; Renard M; Oliver C
Endocrinology; 1994 Feb; 134(2):562-7. PubMed ID: 7905408
[TBL] [Abstract][Full Text] [Related]
6. Malignant somatostatinoma: clinical features and metabolic studies.
Axelrod L; Bush MA; Hirsch HJ; Loo SW
J Clin Endocrinol Metab; 1981 May; 52(5):886-96. PubMed ID: 6112232
[No Abstract] [Full Text] [Related]
7. Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly.
Frohman LA; Szabo M; Berelowitz M; Stachura ME
J Clin Invest; 1980 Jan; 65(1):43-54. PubMed ID: 6243140
[TBL] [Abstract][Full Text] [Related]
8. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
9. Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat.
Bertherat J; Timsit J; Bluet-Pajot MT; Mercadier JJ; Gourdji D; Kordon C; Epelbaum J
J Clin Invest; 1993 Apr; 91(4):1783-91. PubMed ID: 8097209
[TBL] [Abstract][Full Text] [Related]
10. Relationship between hypophyseal portal GHRH and somatostatin and peripheral GH levels in the conscious sheep.
Cataldi M; Magnan E; Guillaume V; Dutour A; Conte-Devolx B; Lombardi G; Oliver C
J Endocrinol Invest; 1994 Oct; 17(9):717-22. PubMed ID: 7868816
[TBL] [Abstract][Full Text] [Related]
11. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
12. On the diagnosis of somatostatinoma.
Somers G; Gepts W; Pipeleers D
Acta Gastroenterol Belg; 1982; 45(7-8):322-6. PubMed ID: 6301190
[No Abstract] [Full Text] [Related]
13. A case of somatostatinoma: responses to food and SMS 201-995 administration.
Davis TM; Bray G; Domin J; Bloom SR
Pancreas; 1988; 3(6):729-33. PubMed ID: 2906126
[TBL] [Abstract][Full Text] [Related]
14. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
[TBL] [Abstract][Full Text] [Related]
15. Stimulated growth hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin levels.
Saggese G; Cesaretti G; Giannessi N; Bracaloni C; Cinquanta L; Cioni C
J Clin Endocrinol Metab; 1992 Feb; 74(2):272-8. PubMed ID: 1346143
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
Kelijman M; Williams TC; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
[TBL] [Abstract][Full Text] [Related]
17. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
Maccario M; Procopio M; Grottoli S; Oleandri SE; Razzore P; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1995 Dec; 80(12):3774-8. PubMed ID: 8530634
[TBL] [Abstract][Full Text] [Related]
18. The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids.
Lamberts SW; den Holder F; Hofland LJ
Endocrinology; 1989 Feb; 124(2):905-11. PubMed ID: 2492219
[TBL] [Abstract][Full Text] [Related]
19. Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and alpha-subunit-secreting tumors from acromegalic patients responsive to octreotide.
Bertherat J; Turpin G; Rauch C; Li JY; Epelbaum J; Sassolas G; Schaison G
J Clin Endocrinol Metab; 1994 Nov; 79(5):1457-64. PubMed ID: 7962343
[TBL] [Abstract][Full Text] [Related]
20. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin.
Faria AC; Veldhuis JD; Thorner MO; Vance ML
J Clin Endocrinol Metab; 1989 Mar; 68(3):535-41. PubMed ID: 2563734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
